Literature DB >> 21383718

A siege of hepatitis: immune boost for viral hepatitis.

Benoît Callendret1, Christopher Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21383718      PMCID： PMC3862030          DOI： 10.1038/nm0311-252

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

Review 1.  The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications.

Authors:  Anna Maria Di Giacomo; Maurizio Biagioli; Michele Maio
Journal:  Semin Oncol       Date:  2010-10       Impact factor: 4.929

2.  PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver.

Authors:  Holly Maier; Masanori Isogawa; Gordon J Freeman; Francis V Chisari
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 3.  Antiviral resistance and specifically targeted therapy for HCV (STAT-C).

Authors:  A J V Thompson; J G McHutchison
Journal:  J Viral Hepat       Date:  2009-06       Impact factor: 3.728

4.  Integrating genomic signatures for immunologic discovery.

Authors:  W Nicholas Haining; E John Wherry
Journal:  Immunity       Date:  2010-02-26       Impact factor: 31.745

5.  Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.

Authors:  Rachel H McMahan; Lucy Golden-Mason; Michael I Nishimura; Brian J McMahon; Michael Kemper; Todd M Allen; David R Gretch; Hugo R Rosen
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

6.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

7.  The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.

Authors:  Bijan Raziorrouh; Winfried Schraut; Tilman Gerlach; Daniela Nowack; Norbert H Grüner; Axel Ulsenheimer; Reinhart Zachoval; Martin Wächtler; Michael Spannagl; Jürgen Haas; Helmut M Diepolder; Maria-Christina Jung
Journal:  Hepatology       Date:  2010-11-09       Impact factor: 17.425

Review 8.  Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.

Authors:  Gordon J Freeman; E John Wherry; Rafi Ahmed; Arlene H Sharpe
Journal:  J Exp Med       Date:  2006-09-25       Impact factor: 14.307

9.  Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.

Authors:  Nobuhiro Nakamoto; Hyosun Cho; Abraham Shaked; Kim Olthoff; Mary E Valiga; Mary Kaminski; Emma Gostick; David A Price; Gordon J Freeman; E John Wherry; Kyong-Mi Chang
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

10.  Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection.

Authors:  Sang-Jun Ha; Scott N Mueller; E John Wherry; Daniel L Barber; Rachael D Aubert; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307
View more
  11 in total

Review 1.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

Review 2.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 3.  Immune control and failure in HCV infection--tipping the balance.

Authors:  Lynn B Dustin; Siobhán B Cashman; Stephen M Laidlaw
Journal:  J Leukoc Biol       Date:  2014-07-11       Impact factor: 4.962

4.  Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice.

Authors:  Joseph S Dolina; Thomas J Braciale; Young S Hahn
Journal:  Hepatology       Date:  2014-02-28       Impact factor: 17.425

Review 5.  Protective immunity against hepatitis C: many shades of gray.

Authors:  Mohamed S Abdel-Hakeem; Naglaa H Shoukry
Journal:  Front Immunol       Date:  2014-06-16       Impact factor: 7.561

Review 6.  The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.

Authors:  Siobhán B Cashman; Brian D Marsden; Lynn B Dustin
Journal:  Front Immunol       Date:  2014-11-10       Impact factor: 7.561

7.  HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.

Authors:  Norma Rallón; Marcial García; Javier García-Samaniego; Noelia Rodríguez; Alfonso Cabello; Clara Restrepo; Beatriz Álvarez; Rosa García; Miguel Górgolas; José M Benito
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

8.  Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

Authors:  Hassen Kared; Thomas Fabre; Nathalie Bédard; Julie Bruneau; Naglaa H Shoukry
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

9.  Lipidoid Nanoparticles Containing PD-L1 siRNA Delivered In Vivo Enter Kupffer Cells and Enhance NK and CD8(+) T Cell-mediated Hepatic Antiviral Immunity.

Authors:  Joseph S Dolina; Sun-Sang J Sung; Tatiana I Novobrantseva; Tuyen M Nguyen; Young S Hahn
Journal:  Mol Ther Nucleic Acids       Date:  2013-02-19       Impact factor: 10.183

10.  Coupling to the surface of liposomes alters the immunogenicity of hepatitis C virus-derived peptides and confers sterile immunity.

Authors:  Akira Takagi; Nobuharu Kobayashi; Maiko Taneichi; Tetsuya Uchida; Toshitaka Akatsuka
Journal:  Biochem Biophys Res Commun       Date:  2012-11-15       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.